A Trial to Evaluate a New Strategy in the Functional Assessment of 3-vessel Disease Using the SYNTAX II Score in Patients Treated With PCI

This study is currently recruiting participants. (see Contacts and Locations)
Verified April 2014 by ECRI bv
Sponsor:
Collaborators:
Boston Scientific Corporation
Volcano Corporation
Information provided by (Responsible Party):
ECRI bv
ClinicalTrials.gov Identifier:
NCT02015832
First received: December 13, 2013
Last updated: August 21, 2014
Last verified: April 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2018
  Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)